Sumitomo Mitsui Trust Holdings, Inc. Exact Sciences Corp Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

  • $168 Billion
  • Q3 2025

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,286,595 shares of EXAS stock, worth $86.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,286,595
Previous 173,136 643.11%
Holding current value
$86.2 Million
Previous $9.2 Million 665.1%
% of portfolio
0.04%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025
BUY
$40.91 - $56.0 $45.6 Million - $62.4 Million
1,113,459 Added 643.11%
1,286,595 $70.4 Million
Q2 2025

Jul 31, 2025
SELL
$40.31 - $58.08 $15.9 Million - $22.9 Million
-394,370 Reduced 69.49%
173,136 $9.2 Million
Q1 2025

Apr 25, 2025
SELL
$43.04 - $58.51 $16.2 Million - $22.1 Million
-377,455 Reduced 39.94%
567,506 $24.6 Million
Q4 2024

Jan 28, 2025
SELL
$49.33 - $71.97 $5.18 Million - $7.55 Million
-104,974 Reduced 10.0%
944,961 $53.1 Million
Q3 2024

Nov 05, 2024
SELL
$42.43 - $70.83 $3.94 Million - $6.58 Million
-92,841 Reduced 8.12%
1,049,935 $71.5 Million
Q2 2024

Jul 19, 2024
SELL
$41.33 - $74.26 $34.3 Million - $61.7 Million
-830,816 Reduced 42.1%
1,142,776 $48.3 Million
Q1 2024

Apr 19, 2024
SELL
$56.27 - $73.77 $13.3 Million - $17.4 Million
-235,658 Reduced 10.67%
1,973,592 $136 Million
Q4 2023

Jan 30, 2024
SELL
$59.06 - $75.72 $11.7 Million - $15 Million
-198,252 Reduced 8.23%
2,209,250 $163 Million
Q3 2023

Oct 30, 2023
SELL
$65.94 - $99.04 $15.7 Million - $23.5 Million
-237,348 Reduced 8.97%
2,407,502 $164 Million
Q2 2023

Jul 31, 2023
SELL
$62.68 - $95.05 $71.1 Million - $108 Million
-1,133,545 Reduced 30.0%
2,644,850 $248 Million
Q1 2023

Apr 27, 2023
SELL
$47.19 - $70.77 $74.9 Million - $112 Million
-1,586,204 Reduced 29.57%
3,778,395 $256 Million
Q4 2022

Jan 30, 2023
SELL
$30.35 - $53.15 $35 Million - $61.3 Million
-1,152,546 Reduced 17.68%
5,364,599 $266 Million
Q3 2022

Oct 21, 2022
BUY
$31.97 - $49.37 $22.7 Million - $35 Million
709,540 Added 12.22%
6,517,145 $212 Million
Q2 2022

Jul 26, 2022
BUY
$35.61 - $76.23 $6.28 Million - $13.4 Million
176,261 Added 3.13%
5,807,605 $229 Million
Q1 2022

Apr 27, 2022
SELL
$57.56 - $82.54 $14.5 Million - $20.8 Million
-251,836 Reduced 4.28%
5,631,344 $394 Million
Q4 2021

Feb 02, 2022
BUY
$72.5 - $100.68 $87.3 Million - $121 Million
1,203,450 Added 25.72%
5,883,180 $458 Million
Q3 2021

Oct 25, 2021
BUY
$90.24 - $124.05 $84.5 Million - $116 Million
936,245 Added 25.01%
4,679,730 $447 Million
Q2 2021

Aug 02, 2021
BUY
$93.66 - $139.27 $100 Million - $149 Million
1,067,298 Added 39.88%
3,743,485 $465 Million
Q1 2021

Apr 30, 2021
BUY
$116.57 - $155.01 $97.6 Million - $130 Million
836,874 Added 45.5%
2,676,187 $353 Million
Q4 2020

Feb 05, 2021
BUY
$99.61 - $142.12 $115 Million - $164 Million
1,156,192 Added 169.25%
1,839,313 $244 Million
Q3 2020

Oct 30, 2020
BUY
$72.92 - $102.01 $6.94 Million - $9.71 Million
95,224 Added 16.2%
683,121 $69.6 Million
Q2 2020

Jul 27, 2020
SELL
$55.75 - $92.75 $26,091 - $43,407
-468 Reduced 0.08%
587,897 $51.1 Million
Q1 2020

Apr 27, 2020
BUY
$37.9 - $104.44 $952,730 - $2.63 Million
25,138 Added 4.46%
588,365 $34.1 Million
Q4 2019

Jan 31, 2020
BUY
$77.66 - $99.74 $6.19 Million - $7.95 Million
79,728 Added 16.49%
563,227 $52.1 Million
Q3 2019

Oct 31, 2019
SELL
$90.37 - $122.49 $3.13 Million - $4.24 Million
-34,632 Reduced 6.68%
483,499 $43.7 Million
Q2 2019

Jul 29, 2019
BUY
$89.51 - $118.04 $46.4 Million - $61.2 Million
518,131 New
518,131 $61.2 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
164M
Call Options Held
2.21M
Put Options Held
1.69M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email